StonvexLoading…
StonvexStonvexStonvexCore line items from NVST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $705.50M | $2.72B | $1.97B | $1.30B |
Operating Income | $62.50M | $216.10M | $142.80M | $85.30M |
Net Income | $38.70M | $47.00M | $14.10M | $26.40M |
EPS (Diluted) | $0.23 | $0.28 | $0.08 | $0.26 |
Total Assets | $5.58B | $5.68B | $5.64B | $5.66B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.08B | $1.21B | $1.13B | $1.11B |
Free Cash Flow OCF − CapEx | $-15.80M | $230.40M | $138.70M | $70.80M |
Shares Outstanding | 162.90M | 163.80M | 165.00M | 166.80M |